InMode (INMD) Scheduled to Post Earnings on Wednesday

InMode (NASDAQ:INMD) is scheduled to announce its earnings results before the market opens on Wednesday, October 30th. Analysts expect the company to announce earnings of $0.44 per share for the quarter. Investors that are interested in registering for the company’s conference call can do so using this link.

InMode (NASDAQ:INMD) last announced its quarterly earnings results on Thursday, August 1st. The healthcare company reported $0.34 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.38 by ($0.04). InMode had a net margin of 35.81% and a return on equity of 21.00%. The firm had revenue of $102.60 million for the quarter, compared to analyst estimates of $104.81 million. During the same period last year, the firm posted $0.65 EPS. The business’s revenue was down 24.6% compared to the same quarter last year. On average, analysts expect InMode to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.

InMode Stock Performance

Shares of INMD opened at $18.35 on Wednesday. InMode has a 1 year low of $14.87 and a 1 year high of $26.80. The company has a market cap of $1.54 billion, a price-to-earnings ratio of 8.70 and a beta of 2.17. The firm has a fifty day moving average of $16.38 and a 200-day moving average of $17.38.

Analyst Ratings Changes

Several equities analysts have recently issued reports on INMD shares. Needham & Company LLC reissued a “hold” rating on shares of InMode in a report on Thursday, October 10th. Canaccord Genuity Group cut their price objective on shares of InMode from $21.00 to $16.00 and set a “hold” rating on the stock in a research note on Friday, July 12th. BTIG Research began coverage on shares of InMode in a research note on Thursday, October 17th. They set a “buy” rating and a $25.00 price objective on the stock. Barclays cut their price objective on shares of InMode from $29.00 to $27.00 and set an “overweight” rating on the stock in a research note on Monday, October 14th. Finally, Jefferies Financial Group cut shares of InMode from a “buy” rating to a “hold” rating and cut their price objective for the company from $21.00 to $19.00 in a research note on Tuesday, July 23rd. Four equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $22.60.

About InMode

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures.